The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -89.17%.However, over the last six months, we can see a stronger performance of -59.81%. Over the last 30 days, the price of SXTC has leaped by -9.47%. And in the last five days, it has surged by 10.12%.
China SXT Pharmaceuticals Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $6.39 on 12/29/23 and the lowest value was $0.36 on 12/05/24.
52-week price history of SXTC Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. China SXT Pharmaceuticals Inc’s current trading price is -93.27% away from its 52-week high, while its distance from the 52-week low is 20.45%. The stock’s price range during this period has varied between$0.36 and $6.39. The China SXT Pharmaceuticals Inc’s shares, which operate in the Healthcare, saw a trading volume of around 21.49 million for the day, a figure considerably higher than their average daily volume of 0.6 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
China SXT Pharmaceuticals Inc (SXTC) has experienced a quarterly decline of -23.80% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.52M and boasts a workforce of 75 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6881, with a change in price of -0.6690. Similarly, China SXT Pharmaceuticals Inc recorded 688,378 in trading volume during the last 100 days, posting a change of -60.87%.
SXTC’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SXTC stands at 0.19. Similarly, the long-term debt-to-equity ratio is also 0.02.
SXTC Stock Stochastic Average
China SXT Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 15.83%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 47.87%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 20.55% and 12.60%, respectively.
